EAPC Premium Access

Rapid fire abstracts - Secondary Prevention and Rehabilitation

Event: ESC Preventive Cardiology 2021
Topic: Risk Factors and Prevention
Session type: Abstract Sessions
Date: 17 April 2021
Time: 08:00 - 08:45

Session

5 presentations in this session

Cost-effectiveness of a cardiovascular polypill strategy (aspirin, atorvastatin, ramipril) for the secondary prevention of cardiovascular disease based on real life improvement in risk factor control

Speaker: Mr G. Rubio (Barcelona, ES)
Thumbnail

Cardiac rehabilitation is associated with lower 1-year all-cause mortality in primary pulmonary hypertension

Speaker: Mr G. Kleinnibbelink (Nijmegen, NL)
Thumbnail

Associations of severity of liver damages with physical function and prognosis in patients with heart failure

Speaker: Mr T. Noda (Sagamihara, JP)
Thumbnail

Association of type 2 diabetes mellitus and mortality after coronary artery bypass graft surgery- a meta analysis

Speaker: Ms A. Abdul Razzack (Hyderabad, IN)
Thumbnail

How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?

Speaker: Mr D. Carcedo (Barcelona, ES)
Thumbnail

5 speakers from this session

Mr Gabriel Rubio

Ferrer Internacional, Barcelona (Spain)
0 follower

Mr Geert Kleinnibbelink

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Mr Takumi Noda

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)
0 follower

Ms Aminah Abdul Razzack

Dr NTR University of Health Sciences, Hyderabad (India)
0 follower

Mr David Carcedo

, Barcelona (Spain)
0 follower

This platform is supported by

logo Novo Nordisk